Mendelian Susceptibility to Mycobacterial Disease: Retrospective Clinical and Genetic Study in Mexico
Abstract Mendelian susceptibility to mycobacterial disease (MSMD) is a rare genetic disorder characterized by impaired immunity against intracellular pathogens, such as mycobacteria, attenuated Mycobacterium bovis-Bacillus Calmette–Guérin (BCG) vaccine strains, and environmental mycobacteria in otherwise healthy individuals. Retrospective study reviewed the clinical, immunological, and genetic characteristics of patients with MSMD in Mexico. Overall, 22 patients diagnosed with MSMD from 2006 to 2021 were enrolled: 14 males (64%) and eight females. After BCG vaccination, 12 patients (70%) developed BCG infection. Furthermore, 6 (22%) patients developed bacterial infections mainly caused by Salmonella, as what is described next in the text is fungal infections, particularly Histoplasma. Seven patients died of disseminated BCG disease. Thirteen different pathogenic variants were identified in IL12RB1 (n = 13), IFNGR1 (n = 3), and IFNGR2 (n = 1) genes. Interleukin-12Rβ1 deficiency is the leading cause of MSMD in our cohort. Morbidity and mortality were primarily due to BCG infection..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Journal of clinical immunology - 43(2022), 1 vom: 31. Aug., Seite 123-135 |
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
BCG vaccine |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s10875-022-01357-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR049404652 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR049404652 | ||
| 003 | DE-627 | ||
| 005 | 20230510060712.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10875-022-01357-8 |2 doi | |
| 035 | |a (DE-627)SPR049404652 | ||
| 035 | |a (SPR)s10875-022-01357-8-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Peñafiel Vicuña, Ana Karen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Mendelian Susceptibility to Mycobacterial Disease: Retrospective Clinical and Genetic Study in Mexico |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 520 | |a Abstract Mendelian susceptibility to mycobacterial disease (MSMD) is a rare genetic disorder characterized by impaired immunity against intracellular pathogens, such as mycobacteria, attenuated Mycobacterium bovis-Bacillus Calmette–Guérin (BCG) vaccine strains, and environmental mycobacteria in otherwise healthy individuals. Retrospective study reviewed the clinical, immunological, and genetic characteristics of patients with MSMD in Mexico. Overall, 22 patients diagnosed with MSMD from 2006 to 2021 were enrolled: 14 males (64%) and eight females. After BCG vaccination, 12 patients (70%) developed BCG infection. Furthermore, 6 (22%) patients developed bacterial infections mainly caused by Salmonella, as what is described next in the text is fungal infections, particularly Histoplasma. Seven patients died of disseminated BCG disease. Thirteen different pathogenic variants were identified in IL12RB1 (n = 13), IFNGR1 (n = 3), and IFNGR2 (n = 1) genes. Interleukin-12Rβ1 deficiency is the leading cause of MSMD in our cohort. Morbidity and mortality were primarily due to BCG infection. | ||
| 650 | 4 | |a BCG vaccine |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Mendelian susceptibility to mycobacterial disease |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Interleukin-12 |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Interferon-gamma |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a IL-12Rβ1 |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Histoplasma |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Yamazaki Nakashimada, Marco |4 aut | |
| 700 | 1 | |a León Lara, Ximena |4 aut | |
| 700 | 1 | |a Mendieta Flores, Elizabeth |4 aut | |
| 700 | 1 | |a Nuñez Núñez, María Enriqueta |4 aut | |
| 700 | 1 | |a Lona-Reyes, Juan Carlos |4 aut | |
| 700 | 1 | |a Hernández Nieto, Leticia |4 aut | |
| 700 | 1 | |a Ramírez Vázquez, María Guadalupe |4 aut | |
| 700 | 1 | |a Barroso Santos, Joel |4 aut | |
| 700 | 1 | |a López Iñiguez, Álvaro |4 aut | |
| 700 | 1 | |a González, Yolanda |4 aut | |
| 700 | 1 | |a Torres, Martha |4 aut | |
| 700 | 1 | |a Lezana Fernández, José Luis |4 aut | |
| 700 | 1 | |a Román Montes, Carla M. |4 aut | |
| 700 | 1 | |a Medina-Torres, Edgar Alejandro |4 aut | |
| 700 | 1 | |a González Serrano, Edith |4 aut | |
| 700 | 1 | |a Bustamante Ogando, Juan Carlos |4 aut | |
| 700 | 1 | |a Lugo Reyes, Saúl |4 aut | |
| 700 | 1 | |a Zavaleta Martínez, Oscar |4 aut | |
| 700 | 1 | |a Staines Boone, Aidé Tamara |4 aut | |
| 700 | 1 | |a Venegas Montoya, Edna |4 aut | |
| 700 | 1 | |a Aguilar Gómez, Nancy Evelyn |4 aut | |
| 700 | 1 | |a Soudeé, Camille |4 aut | |
| 700 | 1 | |a Jouanguy, Emmanuelle |4 aut | |
| 700 | 1 | |a Puel, Anne |4 aut | |
| 700 | 1 | |a Boisson-Dupuis, Stéphanie |4 aut | |
| 700 | 1 | |a Pedraza Sánchez, Sigifredo |4 aut | |
| 700 | 1 | |a Casanova, Jean-Laurent |4 aut | |
| 700 | 1 | |a Espinosa Rosales, Francisco |4 aut | |
| 700 | 1 | |a Espinosa Padilla, Sara |4 aut | |
| 700 | 1 | |a Bustamante, Jacinta |4 aut | |
| 700 | 1 | |a Blancas Galicia, Lizbeth |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical immunology |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1981 |g 43(2022), 1 vom: 31. Aug., Seite 123-135 |w (DE-627)SPR014233401 |w (DE-600)2016755-6 |x 1573-2592 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2022 |g number:1 |g day:31 |g month:08 |g pages:123-135 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10875-022-01357-8 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2022 |e 1 |b 31 |c 08 |h 123-135 | ||